tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRVS Stock Latest News

Corvus Pharmaceuticals confirms plans to announce results of Soquelitinib trial
The FlyCorvus Pharmaceuticals confirms plans to announce results of Soquelitinib trial
14d ago
CRVS
Corvus presents final data from soquelitinib Phase 1/1b T cell lymphoma trial
PremiumThe Fly
Corvus presents final data from soquelitinib Phase 1/1b T cell lymphoma trial
1M ago
CRVS
Corvus Pharmaceuticals management to meet with Cantor
PremiumThe Fly
Corvus Pharmaceuticals management to meet with Cantor
2M ago
CRVS
Corvus Pharmaceuticals Reports Positive Q3 Earnings Call
PremiumCompany Announcements
Corvus Pharmaceuticals Reports Positive Q3 Earnings Call
2M ago
CRVS
Corvus Pharmaceuticals Advances Clinical Trials for Soquelitinib
PremiumCompany Announcements
Corvus Pharmaceuticals Advances Clinical Trials for Soquelitinib
3M ago
CRVS
Corvus Pharmaceuticals reports Q3 EPS (12c), consensus (12c)
PremiumThe FlyCorvus Pharmaceuticals reports Q3 EPS (12c), consensus (12c)
3M ago
CRVS
Corvus Pharmaceuticals price target raised to $13 from $11 at Mizuho
Premium
The Fly
Corvus Pharmaceuticals price target raised to $13 from $11 at Mizuho
3M ago
CRVS
CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CRVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
CRVS
Corvus Pharmaceuticals’ Soquelitinib Study: A Potential Game-Changer for Atopic Dermatitis
PremiumCompany Announcements
Corvus Pharmaceuticals’ Soquelitinib Study: A Potential Game-Changer for Atopic Dermatitis
3M ago
CRVS
Corvus Pharmaceuticals’ Phase 3 Study on Soquelitinib: A Potential Game-Changer in Lymphoma Treatment
PremiumCompany Announcements
Corvus Pharmaceuticals’ Phase 3 Study on Soquelitinib: A Potential Game-Changer in Lymphoma Treatment
3M ago
CRVS
Corvus Pharmaceuticals initiated with an Overweight at Barclays
PremiumThe Fly
Corvus Pharmaceuticals initiated with an Overweight at Barclays
3M ago
CRVS
Corvus Pharmaceuticals Appoints David Moore as Director
PremiumCompany Announcements
Corvus Pharmaceuticals Appoints David Moore as Director
4M ago
8K
CRVS
Corvus Pharmaceuticals’ Earnings Call Highlights Progress
PremiumCompany AnnouncementsCorvus Pharmaceuticals’ Earnings Call Highlights Progress
5M ago
CRVS
Corvus Pharmaceuticals’ Clinical Advancements and Strategic Collaborations Boost Investor Confidence
Premium
Ratings
Corvus Pharmaceuticals’ Clinical Advancements and Strategic Collaborations Boost Investor Confidence
5M ago
CRVS
Corvus Pharmaceuticals price target lowered to $15 from $17 at Oppenheimer
Premium
The Fly
Corvus Pharmaceuticals price target lowered to $15 from $17 at Oppenheimer
5M ago
CRVS
Corvus Pharmaceuticals Reports Q2 2025 Progress and Financials
PremiumCompany Announcements
Corvus Pharmaceuticals Reports Q2 2025 Progress and Financials
5M ago
CRVS
Corvus Pharmaceuticals reports Q2 EPS (10c), consensus (12c)
PremiumThe Fly
Corvus Pharmaceuticals reports Q2 EPS (10c), consensus (12c)
5M ago
CRVS
Corvus Pharmaceuticals’ Promising Study on Soquelitinib for Atopic Dermatitis
PremiumCompany Announcements
Corvus Pharmaceuticals’ Promising Study on Soquelitinib for Atopic Dermatitis
7M ago
CRVS
Corvus announces IND application approved by CDE of China NMPA to start trial
PremiumThe Fly
Corvus announces IND application approved by CDE of China NMPA to start trial
7M ago
CRVS
Corvus Pharmaceuticals Holds Annual Stockholders Meeting
PremiumCompany AnnouncementsCorvus Pharmaceuticals Holds Annual Stockholders Meeting
7M ago
8K
CRVS
Corvus Pharmaceuticals Reports Promising Phase 1 Trial Results
Premium
Company Announcements
Corvus Pharmaceuticals Reports Promising Phase 1 Trial Results
8M ago
8K
CRVS
Corvus announces new interim data from Phase 1 trial of soquelitinib
Premium
The Fly
Corvus announces new interim data from Phase 1 trial of soquelitinib
8M ago
CRVS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >